Greg Melder
Papers
1
Total Citations
2
H-Index
1
About
Dr. Greg Melder is a pioneering surgical oncologist whose work centers on the management of rare abdominal and retroperitoneal pathologies, with a particular focus on minimally invasive and robotic-assisted techniques. His major contribution lies in advancing the understanding and surgical treatment of primary retroperitoneal mucinous cystadenomas (PRMCT)—an exceptionally rare group of tumors classified as benign, borderline, or malignant. In his most cited work, Dr. Melder provides a comprehensive literature review alongside a detailed case report of a 59-year-old female with a benign retroperitoneal mucinous cystadenoma, demonstrating the feasibility and efficacy of robotic resection for these complex lesions. This case not only adds a valuable data point to the sparse literature on PRMCT but also establishes a reproducible surgical framework for managing such tumors. With 2 citations to date, this work is gaining traction among specialists in surgical oncology and robotic surgery. Dr. Melder’s research is notable for bridging a critical gap in clinical knowledge—offering both a systematic synthesis of existing evidence and a practical, patient-centered surgical solution. His efforts are helping to standardize care for ultra-rare conditions, making him a key voice in the evolving field of robotic oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1